CAS 292135-78-5
:Benzamida,3-(ciclopropilmetoxi)-N-(3,5-dicloro-1-óxido-4-piridinil)-4-(difluorometoxi)-
- RofluMilast N-Oxide
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
Roflumilast N-Oxide
CAS:Fórmula:C17H14Cl2F2N2O4Pureza:>98.0%(HPLC)Cor e Forma:White to Light yellow to Light orange powder to crystalPeso molecular:419.213,5-Dichloro-4-(3-(Cyclopropylmethoxy)-4-(Difluoromethoxy)Benzamido)Pyridine 1-Oxide
CAS:3,5-Dichloro-4-(3-(Cyclopropylmethoxy)-4-(Difluoromethoxy)Benzamido)Pyridine 1-OxideFórmula:C17H14Cl2F2N2O4Pureza:98%Peso molecular:419.21Roflumilast N-Oxide
CAS:Fórmula:C17H14Cl2F2N2O4Cor e Forma:White To Off-White SolidPeso molecular:419.213-(Cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridinyl)-4-(difluoromethoxy)benzamide
CAS:Fórmula:C17H14Cl2F2N2O4Pureza:95%Cor e Forma:SolidPeso molecular:419.2069Roflumilast N-Oxide
CAS:Fórmula:C17H14Cl2F2N2O4Cor e Forma:White To Light Orange ColourPeso molecular:419.21Roflumilast N-Oxide
CAS:Produto ControladoApplications Roflumilast-N-oxide is the active metabolite of Roflumilast (R639700).
References Chiba, M., et al.: Drug Metab. Dispos., 25, 1022 (1997), Jarvis, B., et al.: Drugs, 59, 891 (2000),Fórmula:C17H14Cl2F2N2O4Cor e Forma:NeatPeso molecular:419.21Roflumilast N-oxide
CAS:Roflumilast N-oxide is an inhibitor of PDE type 4.Fórmula:C17H14Cl2F2N2O4Pureza:98.19% - 99.69%Cor e Forma:SolidPeso molecular:419.2073,5-Dichloro-4-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamido)pyridine 1-oxide
CAS:3,5-Dichloro-4-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamido)pyridine 1-oxideFórmula:C17H14Cl2F2N2O4Pureza:98%Peso molecular:419.21Roflumilast N-oxide
CAS:Roflumilast N-oxide is a drug that is used to treat chronic obstructive pulmonary disease (COPD). It belongs to the group of drugs called phosphodiesterase-4 (PDE4) inhibitors. Roflumilast N-oxide inhibits the production of chemokines and reduces the recruitment of inflammatory cells, which improves lung function. Roflumilast N-oxide has been shown to reduce matrix metalloproteinases in vitro and in an experimental model in mice. In addition, roflumilast N-oxide has been shown to inhibit the transport of erythromycin into bronchial epithelial cells. The LC-MS/MS method is used for the determination of pharmacokinetic parameters for roflumilast N-oxide.
Fórmula:C17H14Cl2F2N2O4Pureza:Min. 95%Peso molecular:419.21 g/molRef: 3D-FR27750
Produto descontinuado












